This inventor holds 2 USPTO granted patents. Top assignees: The Ohio State University, The Translational Genomics Research Institute, The University of Arizona. Active years: 2013-2015.
Company Filing History:


Years Active: 2013-2015
Title: Arthur Y Shaw: Innovator in Cancer Research
Introduction
Arthur Y Shaw is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of cancer research through his innovative inventions. With a total of 2 patents, Shaw's work focuses on developing compounds and methods that can potentially slow the growth of cancer cells.
Latest Patents
Shaw's latest patents include groundbreaking work on "Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles." This patent discloses a 2-aryl-pyridylazole compound and its derivatives, which are useful in inhibiting the growth of cancer cells. The patent also outlines methods for synthesizing the compound and using pharmaceutical compositions containing it to treat cancer patients. Another significant patent is for "DNA methylation inhibitors," which describes various inhibitors identified through a two-component enhanced green fluorescent protein reporter system. These inhibitors can be utilized for cancer therapy and prevention.
Career Highlights
Throughout his career, Shaw has worked with esteemed institutions such as The Ohio State University and the Translational Genomics Research Institute. His research has contributed to the understanding and treatment of cancer, showcasing his commitment to advancing medical science.
Collaborations
Shaw has collaborated with notable colleagues, including Yu-Wei Leu and Haiyong Han. These partnerships have further enriched his research and innovation in the field.
Conclusion
Arthur Y Shaw's contributions to cancer research through his patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to inspire advancements in cancer therapy and prevention.